Novo Nordisk experimental obesity pill has mild-to-moderate side effects in early trial - Reuters.com

Reuters | Sept. 10, 2024, 6:07 p.m. | Original
Novo Nordisk experimental obesity pill has mild-to-moderate side effects in early trial Reuters.com
Top Russian official reports swift advance in Ukraine, rules out talks for now - Reuters.com Tech firms halve business travel in 2023 but Alphabet, Apple lag, study shows - Reuters